Important Information you need to know about diabetes.
Case Manangement Training Modules
Report of a World Health Organization and International Diabetes Federation meeting
The dual epidemic of TB and Diabetes
For versions in Arabic, Russian, French, Spanish, Turkish and German go to http://www.patienten-information.de/kurzinformationen/diabetes/diabetes-und-fuesse
This manual aims to provide an overview of this subject to health care professionals, paramedics and other voluntary services involved in health care promotion
WHO Package of Essential NCD Interventions (PEN)
Accessed March 18,2019
Updated 24 March 2020 (24 Maart 2020)
Tenho hipertensão ou diabetes, como me cuidar na pandemia?
Em tempos da covid-19, pessoas com doenças crônicas precisam reforçar o autocuidado
Guía Clínica – Diabetes Mellitus tipo 1
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...or developing chronic kidney disease (CKD), which in itself is associated with developing CVD. The combination of diabetes with these cardio-renal comorbidities enhances the risk not only for cardiovascular (CV) events but also for CV and all-cause mortality. The current European Society of Cardiology (ESC) Guidelines on the management of cardiovascular disease in patients with diabetes are designed to guide prevention and management of the manifestations of CVD in patients with diabetes based on data published until end of January 2023. Over the last decade, the results of various large cardiovascular outcome trials (CVOTs) in patients with diabetes at high CV risk with novel glucose- lowering agents, such as sodium–glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), but also novel non-steroidal mineralocorticoid receptor antagonists (MRAs), such as finerenone have substantially expanded available therapeutic op-
tions, leading to numerous evidence-based recommendations for the management of this patient population.
more